Appointment Helpline
English
PICK A TIME SLOT
₹ 1100
Dwarka - Delhi
Book an appointment for Consultation
Morning
Afternoon
Evening
Doctor Consultation Charges (Hospital Visit)- Rs. 1100/-
Morning
Afternoon
Evening
Doctor Consultation Charges (Video Consultation) - Rs. 900/-
₹ 1100-900-
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
-
-
-
-
-
- Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
- Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
- Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
- Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
- Life Member- Society of Nuclear Medicine India (SNMI).
- Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
- Radionuclide scans & Therapy
- English
- Hindi
- “Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
- “Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
- Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
- Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
- Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
- Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
- Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
- Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
- Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
- Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
- Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
- Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
- Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
- Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
- Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
- Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Fellowship & Membership
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
- English
- Hindi
- Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
- Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
- Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
- Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
- Life Member- Society of Nuclear Medicine India (SNMI).
- Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
- Radionuclide scans & Therapy
- “Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
- “Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
- Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
- Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
- Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
- Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
- Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
- Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
- Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
- Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
- Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
- Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
- Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
- Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
- Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
- Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Languages Spoken
Fellowship & Membership
Field of Expertise
Awards & Achievements
Talks & Publications
- Radionuclide scans & Therapy
- Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
- Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
- Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
- Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
- Life Member- Society of Nuclear Medicine India (SNMI).
- Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
- English
- Hindi
- “Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
- “Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
- Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
- Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
- Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
- Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
- Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
- Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
- Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
- Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
- Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
- Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
- Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
- Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
- Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
- Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
- “Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
- “Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
- Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
- Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
- Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
- Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
- Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
- Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
- Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
- Life Member- Society of Nuclear Medicine India (SNMI).
- Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
- Radionuclide scans & Therapy
- English
- Hindi
- Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
- Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
- Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
- Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
- Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
- Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
- Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
- Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
- Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
- Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
- Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Awards & Achievements
Fellowship & Membership
Field of Expertise
Languages Spoken
Talks & Publications
- Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
- Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
- Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
- Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
- Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
- Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
- Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
- Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
- Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
- Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
- Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
- Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
- Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
- Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
- Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
- Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
- Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
- Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
- Life Member- Society of Nuclear Medicine India (SNMI).
- Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
- Radionuclide scans & Therapy
- English
- Hindi
- “Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
- “Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
- Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
- Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
- Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
Talks & Publications
Fellowship & Membership
Field of Expertise
Languages Spoken
Awards & Achievements
Blogs
3 min read 
FAQ's
Patients often seek Dr. Ankur’s expertise as the Head of the Department and Consultant in Nuclear Medicine at Manipal Hospitals Delhi due to his specialized knowledge and experience. He offers advanced diagnostic and therapeutic procedures using nuclear imaging techniques to diagnose and manage various medical conditions, including cancer, heart disease, and thyroid disorders. His approach prioritizes patient care, ensuring personalized treatment plans tailored to each individual's needs, ultimately striving for accurate diagnoses and optimal outcomes.
Dr. Ankur Pruthi at Manipal Hospitals Delhi specializes in nuclear medicine. His expertise includes:
-
Radionuclide scans: Imaging techniques using radioactive substances to diagnose conditions such as cancer, heart disease, and bone disorders.
-
Radionuclide therapy: Treatment method utilizing radioactive substances to target and destroy cancer cells or diseased tissue.
If you need services from an acclaimed Nuclear medicine doctor in Delhi, please visit our hospital or book an appointment. To book an appointment with Dr. Ankur Pruthi's Manipal Hospitals Delhi, specializing in nuclear medicine, please call our appointment desk at 1800 102 5555.
He has completed MBBS, DRM (BARC), and DNB (Nuclear Medicine), and has years of expertise specializing in nuclear medicine at Manipal Hospitals Delhi. He offers nuclear medicine to treat various disorders such as cancer and other ailments and has managed to achieve the best possible patient outcomes.
For your initial appointment with Dr. Ankur, please bring any relevant medical records, including previous imaging scans, laboratory results, and medication lists. It's important to provide a detailed medical history and any pertinent information about your condition. If you have insurance, please bring your insurance card and any necessary referral documents.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
